Developing a multimorbidity prognostic score in elderly patients with solid cancer using administrative databases from Italy-Reference-Cited by-同舟云学术

Developing a multimorbidity prognostic score in elderly patients with solid cancer using administrative databases from Italy

Published:2021-09 Issue:3 Volume:2 Page:98-104
ISSN:2643-8909
Container-title:Aging and Cancer
language:en
Short-container-title:Aging and Cancer

Author:

Franchi Matteo¹²^ORCID,Rea Federico¹²,Santucci Claudia³,La Vecchia Carlo³,Boffetta Paolo⁴⁵,Corrao Giovanni¹²

Affiliation:

1. National Centre for Healthcare Research and Pharmacoepidemiology Milan Italy

2. Laboratory of Healthcare Research and Pharmacoepidemiology Department of Statistics and Quantitative Methods University of Milano‐Bicocca Milan Italy

3. Department of Clinical Medicine and Community Health Università degli Studi di Milano Milano Italy

4. Department of Medical and Surgical Sciences University of Bologna Bologna Italy

5. Stony Brook Cancer Center Stony Brook University Stony Brook New York USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/aac2.12036

Reference17 articles.

1. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study

2. Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer

3. The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer

4. Toxicity and response criteria of the Eastern Cooperative Oncology Group

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating socioeconomic disparities in lung cancer diagnosis, treatment and mortality: an Italian cohort study;BMC Public Health;2024-06-07

2. Upfront Advanced Radiotherapy and New Drugs for NSCLC Patients with Synchronous Brain Metastases: Is the Juice Worth the Squeeze? A Real-World Analysis from Lombardy, Italy;Cancers;2023-02-09

3. Developing a comorbidity score in cancer patients using healthcare utilization databases during the COVID ‐19 pandemic: An experience from Italy;Cancer Medicine;2022-12-20

4. Effectiveness and Cost-Effectiveness Profile of Second-Line Treatments with Nivolumab, Pembrolizumab and Atezolizumab in Patients with Advanced Non-Small Cell Lung Cancer;Pharmaceuticals;2022-04-18